US Heart Pump Devices Market Research Report By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), Others) and By End-User (Hospitals & Clinics, A

US Heart Pump Devices Market Overview

As per MRFR analysis, the US Heart Pump Devices Market Size was estimated at 192.39 (USD Million) in 2023. The US Heart Pump Devices Market Industry is expected to grow from 207.2(USD Million) in 2024 to 1,568.11 (USD Million) by 2035. The US Heart Pump Devices Market CAGR (growth rate) is expected to be around 20.201% during the forecast period (2025 - 2035).

Key US Heart Pump Devices Market Trends Highlighted

The US Heart Pump Devices Market is experiencing significant growth driven primarily by the increasing prevalence of heart diseases, which remain a leading cause of mortality in the country. The rising number of patients requiring advanced heart failure treatments is prompting healthcare providers to adopt innovative heart pump technologies. Furthermore, advancements in device design, including miniaturization and improved biocompatibility, are enhancing patient outcomes, thereby fueling market demand.

The trend towards minimally invasive surgical techniques is also noteworthy, as patients often prefer options that reduce hospital stay and recovery time, which aligns well with the growing emphasis on patient-centric care in the US healthcare system. Opportunities in the US market can be explored through the expansion of telehealth services that complement heart pump therapy. By integrating remote monitoring and digital health solutions, healthcare providers can manage patients effectively and ensure better adherence to treatment protocols.

As awareness grows about heart health and patient education improves, there is potential for increased adoption of heart pump devices, particularly among younger populations with lifestyle-related heart conditions. Recent trends indicate a shift towards partnerships and collaborations between medical device manufacturers and healthcare providers to drive innovation and streamline the regulatory process.

As the US Food and Drug Administration continues to evaluate and approve new heart pump technologies at an accelerated pace, this trend is expected to provide a favorable environment for the introduction of advanced devices. Additionally, there is a growing focus on addressing health disparities within heart failure treatment, with initiatives aimed at improving access to heart pump devices for underserved populations. This comprehensive approach fosters an environment rich in innovation, ultimately benefiting the US Heart Pump Devices Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Heart Pump Devices Market Drivers

Increasing Incidence of Heart Diseases in the US

The rising prevalence of heart diseases is a significant driver of growth in the US Heart Pump Devices Market Industry. According to the American Heart Association, heart disease remains the leading cause of death in the United States, claiming approximately 696,000 lives in 2020 alone. Moreover, the Centers for Disease Control and Prevention (CDC) reported that about 18.2 million adults aged 20 and older have coronary artery disease.

As the population ages and lifestyle-related factors contribute to heart complications, the demand for advanced heart pump devices is expected to surge. Notable organizations like Medtronic and Edwards Lifesciences are heavily investing in innovative heart pump technologies to address this escalating demand, thereby significantly influencing the US Heart Pump Devices Market.

Technological Advancements in Heart Pump Devices

Ongoing technological innovations in heart pump devices are propelling growth in the US Heart Pump Devices Market Industry. Recent developments include improvements in miniaturization and biocompatibility of devices, which enhance patient comfort and outcomes. According to a report from the FDA, there has been a 25% annual increase in the approval of novel medical devices and technologies aimed at treating heart conditions.

Companies such as Abbott and Boston Scientific are leading the charge, developing cutting-edge heart pump systems that offer enhanced features and longer-lasting solutions for patients, thus fueling market expansion.

Growing Preference for Minimally Invasive Procedures

The shift toward minimally invasive procedures is driving growth in the US Heart Pump Devices Market Industry. As healthcare providers increasingly adopt these procedures due to their benefits of shorter recovery times and reduced risk of complications, the demand for advanced heart pump technologies is heightened. The American College of Cardiology estimates that minimally invasive cardiac surgeries have shown a 15% increase in adoption over the past five years.

Leading manufacturers, such as Thoratec (a part of Abbott), are focusing on developing and promoting devices designed specifically for these types of procedures, further supporting market growth.

Increase in Research and Development Investment

Investment in Research and Development (R&D) for heart-related technologies is significantly influencing the growth of the US Heart Pump Devices Market Industry. The National Institutes of Health (NIH) reported a 30% increase in funding allocated to cardiovascular research from 2017 to 2022, amounting to billions of dollars.

This funding supports innovation in heart pump device technology, fostering collaborations between research institutions and industry players like Boston Scientific and Medtronic. The commitment to advancing R&D emphasizes the importance of developing new and improved heart pump solutions, aligning well with the rising demand in the US healthcare system as the population ages and healthcare needs grow.

US Heart Pump Devices Market Segment Insights

Heart Pump Devices Market Product Insights

The US Heart Pump Devices Market represents a crucial area in cardiovascular technology geared towards supporting patients with severe heart ailments. Within this market, the Product segment is particularly diverse, encompassing a variety of devices tailored to enhance cardiac function. Ventricular Assist Devices are crucial as they mechanically support the heart, allowing patients to achieve a better quality of life while waiting for a transplant or when surgery is not feasible.

Among these, Left Ventricular Assist Devices often receive more scrutiny due to their role in augmenting the left ventricle's pumping ability, a key area in heart failure management. Right Ventricular Assist Devices complement this by addressing the right side of the heart, reinforcing the importance of dual management in complex cardiac conditions. Moreover, Bi-Ventricular Assist Devices have emerged as a formidable solution, providing comprehensive support for both ventricles, which is essential for patients with severe biventricular failure.

Percutaneous Ventricular Assist Devices are pioneering advancements with minimally invasive approaches, making them appealing in emergency situations where immediate cardiac support is critical, while Transcutaneous Ventricular Assist Devices introduce innovative methodologies that can be applied in non-traditional clinical settings or for temporary support. The Intra-Aortic Balloon Pump serves a significant purpose in acute care, improving coronary perfusion and reducing the workload on the heart, which perfectly illustrates the multi-faceted approach to cardiac assist devices.

Lastly, Total Artificial Heart represents the frontier of artificial organ development, offering viability for patients who are not candidates for transplant, albeit requiring an intricate understanding of patient selection and timing. Each of these devices plays a vital role in the landscape of heart failure therapies, illustrating a comprehensive strategy for managing diverse cardiovascular threats and contributing to the ever-evolving field of cardiac care.

This segmentation reflects a robust innovation pipeline and highlights a variety of potential avenues for market growth as patient needs and technological advancements align. The consolidation of these devices underscores the ongoing evolution in treating heart-related ailments, driving research and discussions on their application in clinical practices across the US.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Heart Pump Devices Market Device Type Insights

The US Heart Pump Devices Market is notably segmented into various Device Types, primarily focusing on Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices, which play critical roles in the management of heart failure and advanced cardiac conditions. Implantable Heart Pump Devices are increasingly preferred due to their effectiveness in providing continuous support to patients with severe heart ailments; they enable long-term management of heart diseases, offering both improved quality of life and increased survival rates.

Meanwhile, Extracorporeal Heart Pump Devices are significant for their role in temporary support during surgical procedures or emergencies, as their ability to provide immediate hemodynamic support can be life-saving. As the US healthcare system continues to advance in technology, these Device Types are set to experience growth driven by an aging population and a rising prevalence of cardiovascular diseases. Moreover, ongoing Research and Development initiatives are expected to lead to innovative solutions within these categories, thus addressing the unique challenges faced by clinicians and patients alike, while enhancing treatment protocols in the cardiovascular landscape.

Heart Pump Devices Market Therapy Insights

The Therapy segment within the US Heart Pump Devices Market plays a crucial role in addressing advanced heart failure through various treatment pathways. Specifically, the Bridge-to-candidacy approach serves as a fundamental strategy for patients awaiting heart transplants, facilitating immediate support while they await evaluation and listing. Meanwhile, the Bridge-to-transplant option maintains its importance by providing critical care to those who are transplant-eligible yet face significant cardiovascular risk.

Destination Therapy has gained traction as a viable long-term solution for patients who are not candidates for transplantation, effectively improving quality of life and survival rates in those with persistent heart failure. Additionally, other therapies within this market segment continue to evolve with innovative technologies addressing diverse patient needs. The increasing prevalence of heart diseases in the US, along with advancements in heart pump technologies, is likely to drive growth in this sector, underlining its significance within the overall US Heart Pump Devices Market landscape.

This industry is fortified by ongoing research and development efforts aimed at improving therapeutic outcomes and enhancing patient quality of life. Such dynamics present opportunities for further innovations in heart pump treatments that cater to both patients' immediate and long-term health requirements.

Heart Pump Devices Market End-User Insights

The US Heart Pump Devices Market demonstrates a dynamic growth pattern across various End-User segments, showing a robust demand for heart pump technologies. Hospitals and clinics play a central role in this market due to their ability to provide comprehensive cardiac care, which is crucial for the management of heart diseases.

Ambulatory Surgical Centers and Research Institutes are also significant players as they cater to outpatient procedures and focus on the innovative development and research of heart pump technologies. These facilities contribute to efficient patient care and transformative research that drive advancements in heart pump device effectiveness and safety.

Other healthcare entities further complement the market by addressing diverse patient needs with tailored heart pump solutions. Given that the US has a high prevalence of cardiovascular diseases, these segments are pivotal not only for patient treatment but also for ongoing research and development in the heart pump device industry. The future growth anticipates an increased focus on innovative technologies and expanding accessibility of treatment options across all these End-User categories, further enhancing the heart pump device landscape.

US Heart Pump Devices Market Key Players and Competitive Insights

The US Heart Pump Devices Market has been increasingly competitive due to the rising prevalence of cardiovascular diseases and advancements in medical technology. A sizable number of established companies and new entrants are striving to develop innovative heart pump devices that cater to varying patient needs, such as Left Ventricular Assist Devices (LVADs), Total Artificial Hearts, and Intra-Aortic Balloon Pumps. The market's competitive landscape is characterized by significant investments in research and development, regulatory approvals, and strategic partnerships to enhance product offerings and expand market reach. As a result, companies in this sector are continually adapting their strategies to ensure a foothold in this rapidly evolving market.

Spectrum Dynamics has carved out a notable presence in the US Heart Pump Devices Market by leveraging its advanced technologies and focusing on the development of high-quality heart pump devices. The company has established a reputation for its commitment to innovation and excellence in engineering, which serves as a strong competitive advantage in meeting the rigorous demands of healthcare providers and patients alike. Spectrum Dynamics’ strength lies not only in its product offerings but also in its robust relationships with key stakeholders, including hospitals and medical practitioners. This strategic alignment enables the company to better understand market needs and quickly respond to emerging trends, ultimately ensuring sustained growth and market relevance.

Asahi Kasei has a prominent standing in the US Heart Pump Devices Market, emphasizing a diverse portfolio that includes various cardiac assist devices designed to improve patient outcomes. The company is dedicated to creating advanced medical devices that combine reliability and quality, with key products aimed at enhancing cardiac health care. Asahi Kasei's strengths are rooted in its commitment to research and development, which fosters continuous innovation in heart pump technology. Moreover, the company's strategic mergers and acquisitions bolster its market position by enhancing its product range and technological capabilities. This proactive approach enables Asahi Kasei to adapt to the evolving landscape of the US heart pump device sector, ensuring the delivery of cutting-edge solutions tailored to the needs of patients and clinicians alike.

Key Companies in the US Heart Pump Devices Market Include

• Spectrum Dynamics


• Asahi Kasei


• Cleveland Heart


• Medtronic


• Boston Scientific


• Getinge


• CenoMed


• Cardinal Health


• Terumo


• Synchron


• Abiomed


• Jarvik Heart


• Abbott


• Corvida Medical


• ReliantHeart

US Heart Pump Devices Market Industry Developments

Recent developments in the US Heart Pump Devices Market indicate significant advancements and activities among key players such as Medtronic, Abbott, and Boston Scientific. In September 2023, Medtronic announced its new heart pump technology aimed at improving patient outcomes for severe heart failure, reflecting ongoing innovation in the sector. Additionally, Abbott has been making strides with its recent clinical trials targeting advanced heart failure treatments, showcasing the critical shift towards less invasive solutions.

In the mergers and acquisitions landscape, Asahi Kasei acquired a majority stake in a significant heart pump technology company in August 2023, enhancing its position in the market. Furthermore, Boston Scientific completed the acquisition of a startup specializing in heart pump devices in July 2023, which is anticipated to bolster its R&D capabilities.

Over the last 2-3 years, the US Heart Pump Devices Market has witnessed a noted increase in valuation due to rising patient needs and advances in technology, with the market expected to grow substantially as more companies focus on developing innovative solutions for heart failure management. These developments underscore the dynamic nature of the market and the potential for continued growth driven by innovation and strategic partnerships.

US Heart Pump Devices Market Segmentation Insights

Heart Pump Devices Market Product Outlook

• Ventricular Assist Devices


• Left Ventricular Assist Devices


• Right Ventricular Assist Devices


• Bi- Ventricular Assist Devices


• Percutaneous Ventricular Assist Devices


• Transcutaneous Ventricular Assist Devices


• Intra-Aortic Balloon Pumps


• Total Artificial Heart

Heart Pump Devices Market Device Type Outlook

• Implantable Heart Pump Devices


• Extracorporeal Heart Pump Devices

Heart Pump Devices Market Therapy Outlook

• Bridge-to-candidacy (BTC)


• Bridge-to-transplant (BTC)


• Destination Therapy (DT)


• Others

Heart Pump Devices Market End-User Outlook

• Hospitals & Clinics


• Ambulatory Surgical Centers


• Research Institutes


• Others

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	192.39(USD Million)
MARKET SIZE 2024	207.2(USD Million)
MARKET SIZE 2035	1568.11(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	20.201% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Spectrum Dynamics, Asahi Kasei, Cleveland Heart, Medtronic, Boston Scientific, Getinge, CenoMed, Cardinal Health, Terumo, Synchron, Abiomed, Jarvik Heart, Abbott, Corvida Medical, ReliantHeart
SEGMENTS COVERED	Product, Device Type, Therapy, End-User
KEY MARKET OPPORTUNITIES	Aging population growth, Technological advancements in devices, Increasing cardiovascular disease prevalence, Expanding outpatient care settings, Rising investment in R&D initiatives
KEY MARKET DYNAMICS	Technological advancements, Rising cardiovascular diseases, Aging population, Increased healthcare expenditure, Growing demand for minimally invasive procedures
COUNTRIES COVERED	US